Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $832.6 million.

  • Orthofix Medical's Liabilities and Shareholders Equity fell 406.3% to $832.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year decrease of 544.59%. This contributed to the annual value of $893.3 million for FY2024, which is 346.06% down from last year.
  • Latest data reveals that Orthofix Medical reported Liabilities and Shareholders Equity of $832.6 million as of Q3 2025, which was down 406.3% from $837.2 million recorded in Q2 2025.
  • In the past 5 years, Orthofix Medical's Liabilities and Shareholders Equity ranged from a high of $925.3 million in Q4 2023 and a low of $449.7 million during Q3 2022
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $832.6 million (2025), whereas its average is $711.4 million.
  • Per our database at Business Quant, Orthofix Medical's Liabilities and Shareholders Equity plummeted by 1572.9% in 2021 and then surged by 10175.68% in 2023.
  • Quarter analysis of 5 years shows Orthofix Medical's Liabilities and Shareholders Equity stood at $476.6 million in 2021, then fell by 3.78% to $458.6 million in 2022, then soared by 101.76% to $925.3 million in 2023, then decreased by 3.46% to $893.3 million in 2024, then dropped by 6.79% to $832.6 million in 2025.
  • Its last three reported values are $832.6 million in Q3 2025, $837.2 million for Q2 2025, and $823.1 million during Q1 2025.